Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)Benzinga • 07/05/23
Is Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/06/23
Bellerphon Therapeutics stock plunges toward record selloff after lung disease treatment performs worse than placebo in late-stage trialMarket Watch • 06/05/23
Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 06/05/23
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial ResultsGlobeNewsWire • 05/15/23
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 05/11/23
Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial ResultsGlobeNewsWire • 03/31/23
Bellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 03/28/23
Here's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep goingZacks Investment Research • 03/10/23
Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 02/09/23
Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 01/18/23
Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciencesGlobeNewsWire • 01/05/23
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/14/22
Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung DiseaseGlobeNewsWire • 09/27/22
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial ResultsGlobeNewsWire • 08/15/22
Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International ConferenceGlobeNewsWire • 05/12/22
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/11/22